Why the study?
Do monoclonal antibodies directed against HSV glycoproteins protect mice against acute virus-induced neurological disease and death?
Population
Mice inoculated with herpes simplex virus type 1 or type 2 via footpad
Comparison
Monoclonal antibodies HCl or HD1 administered… vs Single intraperitoneal injection of normal serum
Design
Preclinical
Follow-up
7 to 10 days
Authors
Loading...
Supports mAb protection in murine HSV models; leaves open human translation and trials.
Do monoclonal antibodies directed against HSV glycoproteins protect mice against acute virus-induced neurological disease and death?
Monoclonal antibodies against HSV glycoproteins gC and gD can passively immunize mice against acute virus-induced neurological disease and death.
Dix et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: